StonvexLoading…
StonvexStonvexStonvexCore line items from CVNA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $20.32B | $13.67B | $10.77B | $13.60B |
Operating Income | $1.88B | $990.00M | $-80.00M | $-2.35B |
Net Income | $1.41B | $210.00M | $450.00M | $-1.59B |
EPS (Diluted) | $8.45 | $1.59 | $0.75 | $-15.74 |
Total Assets | $13.20B | $8.48B | $7.07B | $8.70B |
Total Liabilities | $9.00B | $7.11B | $7.46B | $9.75B |
Cash & Equivalents | $2.33B | $1.72B | $530.00M | $434.00M |
Free Cash Flow OCF − CapEx | $889.00M | $827.00M | $716.00M | $-1.84B |
Shares Outstanding | 224.28M | 132.21M | 200.58M | 100.83M |